TET2 and hematologic disorder: In particular, several authors showed that vitamin C may be a useful anti-leukemic agent able to restore the dioxygenase activity, thereby attenuating the effects of TET2 dysfunction, a widespread feature of hematological malignancies beyond the mere presence of mutations (25, 27, 29, 47–49).